Company Profile Boards & Staffs Memberships & Partners Academy of Journalism Careers Blog(EN)Contact Us

Our Journals Instruction for Authors Brieflands Policies Publish My Research Journal Management System Article Processing Charges Open Peer Review Publishing Services

Publish My Book

Hepatitis Monthly

Official Journal of Research Center for Gastroenterology and Liver Diseases

Current Issue Accepted Manuscripts All Issues In Press Articles Search

Journal Information Boards and committees Indexing and Listing Sources Journal Metrics Open Peer Review (OPR)Publication Ethics and Malpractice Statement Reviewer and AE Registration Form Support Contact Us

Authors Guide Submit Manuscript

Crossref

1. The Role of Polymorphisms Near IFNL3 Gene as Predictors of Residual HCV RNA in Buffy Coat after Successful Antiviral Therapy

- Seyyed Mohammad Miri

- Heidar Sharafi

- Ali Pouryasin

- Bita Behnava

- Maryam Keshvari

- Shima Salimi

- Pegah Karimi Elizee

- Seyed Moayed Alavian

2. The Role of Polymorphisms Near the IL28B Gene on Response to Peg-Interferon and Ribavirin in Thalassemic Patients With Hepatitis C

- Bita Behnava

- Heidar Sharafi

- Maryam Keshvari

- Ali Pouryasin

- Leila Mehrnoush

- Shima Salimi

- Pegah Karimi Elizee

- Mehran Ghazimoghaddam

- Seyed Moayed Alavian

3. Assessment of Hepatitis C Virus RNA in Peripheral Blood Mononuclear Cells as a Predictor of Response to Pegylated-Interferon and Ribavirin: A Cohort Study

- Seyyed Mohammad Miri

- Heidar Sharafi

- Shima Salimi

- Farah Bokharaei-Salim

- Bita Behnava

- Maryam Keshvari

- Pegah Karimi Elizee

- Hosein Keyvani

- Seyed Moayed Alavian

4. The ITPA and C20orf194 Polymorphisms and Hematological Changes During Treatment With Pegylated-Interferon Plus Ribavirin in Patients With Chronic Hepatitis C

- Mohammad Pouryasin

- Maryam Keshvari

- Heidar Sharafi

- Seyed Moayed Alavian

- Bita Behnava

- Seyed Ehsan Alavian

- Ali Pouryasin

5. Next Steps Toward Eradication of Hepatitis C in the Era of Direct Acting Antivirals

- Khashayar Hesamizadeh

- Heidar Sharafi

- Mohammad Saeid Rezaee-Zavareh

- Bita Behnava

- Seyed Moayed Alavian

6. Efficacy of 24-Week Pegylated Interferon Alpha and Ribavirin Combination Therapy in Highly Selected Patients Infected With Hepatitis C Virus Genotype 1

- Heidar Sharafi

- Seyed Moayed Alavian

- Maryam Keshvari

7. Recommendations for the Clinical Management of Hepatitis C in Iran: A Consensus-Based National Guideline

- Seyed Moayed Alavian

- Behzad Hajarizadeh

- Kamran Bagheri Lankarani

- Heidar Sharafi

- Nasser Ebrahimi Daryani

- Shahin Merat

- Minoo Mohraz

- Masoud Mardani

- Mohamad Reza Fattahi

- Hossein Poustchi

- Mehri Nikbin

- Mahmood Nabavi

- Peyman Adibi

- Masood Ziaee

- Bita Behnava

- Mohammad Saeid Rezaee-Zavareh

- Massimo Colombo

- Hatef Massoumi

- Abdul Rahman Bizri

- Bijan Eghtesad

- Majid Amiri

- Ali Namvar

- Khashayar Hesamizadeh

- Reza Malekzadeh

8. Sofosbuvir Has Come Out of the Magic Box

- Seyed Moayed Alavian

9. Predicting the Outcomes of Combination Therapy in Patients With Chronic Hepatitis C Using Artificial Neural Network

- Forough Sargolzaee Aval

- Nazanin Behnaz

- Mohamad Reza Raoufy

- Seyed Moayed Alavian